Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the reporting period of September 2024. The document specifically details a transaction in own shares executed on September 23, 2024, under the company's share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity. Key transaction details include:
- Shares Purchased: 506,899 ordinary shares
- Price Range: Lowest price of 389.10 pence; Highest price of 395.50 pence
- Volume Weighted Average Price: 392.9671 pence
- Post-Transaction Share Capital: 9,115,151,424 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of the purchased shares. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It is a regulatory disclosure of a completed share transaction. The filing notes that a full breakdown of individual trades is available via the London Stock Exchange and the company's investor website.
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the current total share capital of 9,115,151,424 shares against the latest market data.
- Review the full trade breakdown at the provided RNS link for detailed execution timing.
- Check the company's website for updates on the remaining authorization for the buyback programme.